Mitochondrial diseases (mito) are a highly complex set of rare genetic disorders. Mito can cause any symptom in any organ at any age. They rob the body’s cells of energy causing debilitating and often life-threatening organ dysfunction.
About
MITO
NEWS
Announcing IMP’s New Scientific and Medical Advisory Committee
Announcing IMP’s New Scientific and Medical Advisory Committee IMP is delighted to introduce our new Scientific and Medical Advisory Committee, a […]...
28 March 2026
Read more
New MELAS Consensus: A Critical Resource for Doctors and Patients Worldwide
New MELAS Consensus: A Critical Resource for Doctors and Patients Worldwide In November 2025, leading international experts gathered in Pisa, […]...
28 March 2026
Read more
MitMED – Building a European Centre of Excellence in Mitochondrial Medicine
MitMED – Building a European Centre of Excellence in Mitochondrial Medicine Mitochondria are central regulators of cellular life, integrating metabolism, […]...
28 March 2026
Read more
Growing Recognition of the Patient Voice in Research
Growing Recognition of the Patient Voice in Research A meaningful shift is taking place in the rare disease research landscape: […]...
25 March 2026
Read more
Inside the Mito Town Hall: Insights That Matter
Inside the Mito Town Hall: Insights That Matter The Mito Town Hall meetings have become an important annual touchpoint for […]...
25 March 2026
Read more
Meet
a member
The POLG Foundation
The PolG Foundation is committed to accelerating research efforts to develop effective treatments and, ultimately, a cure for POLG mitochondrial disorders.
Become
a member
Are you thinking of becoming an IMP member?
About
IMP
International Mito Patients is a non-profit network of national patient organisations involved in mito. The national patient organisations support and advocate for patients, fund research, increase awareness and improve education in their country.
By joining forces, IMP represents a large group of patients, creating a stronger voice on an international level.
IMP’s mission is to increase the quality of life for people with mitochondrial disease by facilitating cross-border cooperation and collaboration among national patient organisations.